AndreaBozzo/ceres-open-data-index huggingface dataset:
Compound 529929: Nimodipine M (dehydro-desisopropyl-O-desmethyl, methyl ester)

Chemical compound data from PubChem database. IUPAC Name: 3-O-(2-methoxyethyl) 5-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate. Molecular Formula: C19H20N2O7. Molecular Weight: 388.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525204: Chloromethyl 3-chloropentanoate

Chemical compound data from PubChem database. IUPAC Name: chloromethyl 3-chloropentanoate. Molecular Formula: C6H10Cl2O2. Molecular Weight: 185.05. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399534-T1: [Translated] DRY POWDER PREPARATIONS FOR PRE-DOSED DRY POWDER INHALERS

A dry powder medicament preparation is disclosed. Also methods of forming and loading metered doses of the preparation into dose containers intended for insertion into a dry powder inhaler are disclosed. The preparation is adapted for a dose forming process, which may be based on volumetric filling or electro-dynamic deposition of the powder particles, such that a metered dose of the preparation is characterized by having at least one load of held-together particles joined in a macrostructure of predefined dimensions and presenting an intended mechanical strength. The pharmacologically active ingredient presents at least 50% by mass of particles in a typical aerodynamic diameter range from 1 to 5 mum. Furthermore, a dose thus formed is then loaded into a high barrier container.
Child and Family Services Reviews Update Volume 18, Issue 3, June 2024

This issue of Child and Family Services Reviews Update contains the following sections: Year 2 of the Round 4 CFSRs is Underway, E-Learning Academy Offers Continuing Education Accredited Courses Online, Training Consultations Available for States, Center for States Offers Tools to Support Planning and Implementation of Round 4, Program Improvement Planning Support Services Available Now, and Spanish Translations Updated on Portal.

Metadata-only record linking to the original dataset. Open original dataset below.
From the cell biology to the development of new chemotherapeutic approaches against trypanosomatids: dreams and reality.

Members of the Trypanosomatidae family comprise a large number of species that are causative agents of important diseases such as sleeping sickness, Chagas' disease and Leishmaniasis. These organisms are also of biological interest since they are able to change the morphology according to the environment where they live, through a process of reversible cell transformation, and possess structures and organelles that are not found in mammalian cells. This review analyses the process of transformation, which takes place during the life cycle of Trypanosoma cruzi in the vertebrate and invertebrate hosts. Special attention is given to the interaction of the parasite with vertebrate cells. In addition, the present knowledge of structures and organelles such as the nucleus, the plasma membrane, the sub-pellicular microtubules, the flagellum, the kinetoplast-mitochondrion complex, the peroxisome (glycosome), the acidocalcisome and the structures and organelles involved in the endocytic pathway, is reviewed from a cell biology perspective. The possible use of available data for the development of new anti parasite drugs is also discussed.
Compound 528080: O-Ethyl S-[5-(diisopropylamino)-3-thiapentyl]methylphosphonothiolate

Chemical compound data from PubChem database. IUPAC Name: N-[2-[2-[ethoxy(methyl)phosphoryl]sulfanylethylsulfanyl]ethyl]-N-propan-2-ylpropan-2-amine. Molecular Formula: C13H30NO2PS2. Molecular Weight: 327.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525431: Butane, 2-methyl-3-(methylthio)-

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-3-methylsulfanylbutane. Molecular Formula: C6H14S. Molecular Weight: 118.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Visits to physician offices, hospital outpatient departments, and hospital emergency departments, by age, sex, and race: United States

Data on visits to physician offices, hospital outpatient departments and hospital emergency departments by selected population characteristics. Please refer to the PDF or Excel version of this table in the HUS 2019 Data Finder (https://www.cdc.gov/nchs/hus/contents2019.htm) for critical information about measures, definitions, and changes over time. Note that the data file available here has more recent years of data than what is shown in the PDF or Excel version. Data for 2017 physician office visits are not available.

SOURCE: NCHS, National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey. For more information on the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey, see the corresponding Appendix entries at https://www.cdc.gov/nchs/data/hus/hus17_appendix.pdf.
Treatment Episode Data Set: Admissions (TEDS-A-2004)

<p>The Treatment Episode Data Set -- Admissions (TEDS-A) is a national census data system of annual admissions to substance abuse treatment facilities. TEDS-A provides annual data on the number and characteristics of persons admitted to public and private substance abuse treatment programs that receive public funding. The unit of analysis is a treatment admission. TEDS consists of data reported to state substance abuse agencies by the treatment programs, which in turn report it to SAMHSA.<br />
A sister data system, called the Treatment Episode Data Set -- Discharges (TEDS-D), collects data on discharges from substance abuse treatment facilities. The first year of TEDS-A data is 1992, while the first year of TEDS-D is 2006.<br />
TEDS variables that are required to be reported are called the "Minimum Data Set (MDS)", while those that are optional are called the "Supplemental Data Set (SuDS)".<br />
Variables in the MDS include: information on service setting, number of prior treatments, primary source of referral, sex, race, ethnicity, education, employment status, substance(s) abused, route of administration, frequency of use, age at first use, and whether methadone was prescribed in treatment. Supplemental variables include: diagnosis codes, presence of psychiatric problems, living arrangements, source of income, health insurance, expected source of payment, pregnancy and veteran status, marital status, detailed not in labor force codes, detailed criminal justice referral codes, days waiting to enter treatment, and the number of arrests in the 30 days prior to admissions (starting in 2008).<br />
Substances abused include alcohol, cocaine and crack, marijuana and hashish, heroin, nonprescription methadone, other opiates and synthetics, PCP, other hallucinogens, methamphetamine, other amphetamines, other stimulants, benzodiazepines, other non-benzodiazepine tranquilizers, barbiturates, other non-barbiturate sedatives or hypnotics, inhalants, over-the-counter medications, and other substances.<br />
Created variables include total number of substances reported, intravenous drug use (IDU), and flags for any mention of specific substances.This study has 1 Data Set.</p>
Phoenix: Drug-Related Emergency Department Visits, 2004-2011 - All Misuse and Abuse

Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits involving drug misuse or abuse in the Phoenix metropolitan area, covering 2004-2011. Drug misuse/abuse visits include the use of illicit drugs, nonmedical use of pharmaceuticals, underage drinking and visits where alcohol was combined with another drug.
Compound 529498: 2-Hexanol 3-methylbutanoate

Chemical compound data from PubChem database. IUPAC Name: hexan-2-yl 3-methylbutanoate. Molecular Formula: C11H22O2. Molecular Weight: 186.29. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NIOSH Health Hazard Evaluation Program Noise Measurement Database

This noise database was developed to provide researchers and other interested stakeholders with noise measurement results that the National Institute for Occupational Safety and Health (NIOSH) has collected during health hazard evaluation (HHE) surveys from 1996 through 2013. HHEs are requested by employees or their representatives, or employers, to help learn whether health hazards are present at their workplace. The scope of HHEs varies based on the requestors’ concerns and the NIOSH project officers’ professional judgment. Only noise measurement results are included in this database; however, many HHEs include evaluation of exposures other than noise. Individual HHE reports are published on the NIOSH website. When available, the database provides a direct link to the HHE report for each of the noise measurement results.

The noise database contains workplace noise measurement results from 77 HHE reports, including over 808 personal noise exposure measurements and 582 area noise measurements. It also includes the following information: U.S. state or territory; Occupational Safety and Health Administration (OSHA) region; National Occupational Research Agenda (NORA) sector; North American Industry Classification System (NAICS) code; facility description; type of dosimeter or sound level meter used; whether a hearing conservation program was in place; whether a hearing protection was used; whether octave band data was collected; job title; noise-generating activities; location of noise measurements; start and end date for site visit; type (full-shift, partial-shift, or task-based) and duration of noise measurement; type of noise (continuous, impulsive, or intermittent); exposure to ototoxic chemicals; and results in decibels A-weighted (dBA) and percent dose according to OSHA and NIOSH noise measurement criteria. This database is an ongoing project and will be updated at least yearly to add the most recent HHE noise measurement data.
Household Pulse Survey (HPS): COVID-19 Vaccination among People with Disabilities

Household Pulse Survey (HPS): HPS is a rapid-response survey of adults ages ≥18 years led by the U.S. Census Bureau, in partnership with seven other federal statistical agencies, to measure household experiences during the COVID-19 pandemic. Detailed information on probability sampling using the U.S. Census Bureau’s Master Address File, questionnaires, response rates, and bias assessment is available on the Census Bureau website (https://www.census.gov/data/experimental-data-products/household-pulse-survey.html).

Data from adults age ≥18 years are collected by 20-minute online survey from randomly sampled households stratified by state and the top 15 metropolitan statistical areas (MSAs). Data are weighted to represent total persons age 18 and older living within households and to mitigate possible bias that can result from non-responses and incomplete survey frame. Data from adults age ≥18 years are collected by 20-minute online survey from randomly sampled households stratified by state and the top 15 metropolitan statistical areas (MSAs). For more information on this survey, see https://www.census.gov/programs-surveys/household-pulse-survey.html.

Data are weighted to represent total persons age 18 and older living within households and to mitigate possible bias that can result from non-responses and incomplete survey frame. Responses in the Household Pulse Survey (https://www.census.gov/programs-surveys/household-pulse-survey.html) are self-reported. Estimates of vaccination coverage may differ from vaccine administration data reported at COVID-19 Vaccinations in the United States (https://covid.cdc.gov/covid-data-tracker/#vaccinations).
A TARGETed© Approach to Working with Traumatized Youth and Families - Program Manual for the Illinois PII Project

This PII grantee program manual provides detailed information about the implementation process of the Illinois Trauma Focus Model for Reducing Long-Term Foster Care project. The purpose of the manual is to assist others in the field in replicating or adapting the Trauma Affect Regulation: Guide for Education and Therapy (TARGET©) intervention for their local use. Readers will find reflections, lessons learned, and other practical information based on the experience of the Illinois team. The manual can be especially helpful if you are considering implementation of the intervention, interested in addressing the needs of similar target populations, or interested in lessons learned from real-world implementation experiences. Together, the PII program manuals help to build a base of replicable interventions that can serve the complex needs of diverse communities of children and families.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 525833: N,N-Dimethyl-N'-(4-methylphenyl)-propionamidine

Chemical compound data from PubChem database. IUPAC Name: N,N-dimethyl-N'-(4-methylphenyl)propanimidamide. Molecular Formula: C12H18N2. Molecular Weight: 190.28. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Unintentional Drug Overdose Death Rate by Race/Ethnicity

<strong>A. SUMMARY</strong> 
This dataset includes unintentional drug overdose death rates by race/ethnicity by year. This dataset is created using data from the California Electronic Death Registration System (CA-EDRS) via the Vital Records Business Intelligence System (VRBIS). Substance-related deaths are identified by reviewing the cause of death. Deaths caused by opioids, methamphetamine, and cocaine are included. Homicides and suicides are excluded. Ethnic and racial groups with fewer than 10 events are not tallied separately for privacy reasons but are included in the “all races” total.   

Unintentional drug overdose death rates are calculated by dividing the total number of overdose deaths by race/ethnicity by the total population size for that demographic group and year and then multiplying by 100,000. The total population size is based on estimates from the <u><a href="https://www.census.gov/data/tables/time-series/demo/popest/2020s-counties-detail.html">US Census Bureau County Population Characteristics for San Francisco, 2022 Vintage</a></u> by age, sex, race, and Hispanic origin. 

These data differ from the data shared in the <u><a href="https://data.sfgov.org/dataset/Preliminary-Accidental-Drug-Overdose-Deaths/jxrr-bmra"> Preliminary Unintentional Drug Overdose Death by Year dataset </a></u> since this dataset uses finalized counts of overdose deaths associated with cocaine, methamphetamine, and opioids only.  

<strong>B. HOW THE DATASET IS CREATED</strong> 
This dataset is created by copying data from the <u><a href="https://www.csuhsf.org/substance-use-trends-san-francisco">Annual Substance Use Trends in San Francisco report</a></u> from the San Francisco Department of Public Health Center on Substance Use and Health. 

<strong>C. UPDATE PROCESS</strong> 
This dataset will be updated annually, typically at the end of the year. 

<strong>D. HOW TO USE THIS DATASET</strong> 
N/A  

<strong>E. RELATED DATASETS</strong> 
<u><a href="https://data.sfgov.org/d/ed3a-sn39">Overdose-Related 911 Responses by Emergency Medical Services</a></u> 
<u><a href="https://data.sfgov.org/d/jxrr-bmra">Preliminary Unintentional Drug Overdose Deaths</a></u> 
<u><a href="https://data.sfgov.org/d/ubf6-e57x">San Francisco Department of Public Health Substance Use Services</a></u>

<strong>F. CHANGE LOG</strong> 
<UL><LI>12/16/2024 - Updated with 2023 data. Asian/Pacific Islander race/ethnicity group was changed to Asian. 
<LI>12/16/2024 - Past year totals by race/ethnicity were revised after obtaining accurate race/ethnicity for some decedents that were previously marked as “unknown” race/ethnicity.
NNDSS - TABLE 1S. Invasive pneumococcal disease, all ages, Confirmed to Invasive pneumococcal disease, all ages, Probable

NNDSS - TABLE 1S. Invasive pneumococcal disease, all ages, Confirmed to Invasive pneumococcal disease, all ages, Probable - 2022. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notes:

•	These are weekly cases of selected infectious national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables available at https://www.cdc.gov/nndss/data-statistics/index.html. Cases reported by state health departments to CDC for weekly publication are subject to ongoing revision of information and delayed reporting. Therefore, numbers listed in later weeks may reflect changes made to these counts as additional information becomes available. Case counts in the tables are presented as published each week. See also Guide to Interpreting Provisional and Finalized NNDSS Data at https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
• Notices, errata, and other notes are available in the Notice To Data Users page at https://wonder.cdc.gov/nndss/NTR.html.
•	The list of national notifiable infectious diseases and conditions and their national surveillance case definitions are available at https://ndc.services.cdc.gov/. This list incorporates the Council of State and Territorial Epidemiologists (CSTE) position statements approved by CSTE for national surveillance.

Footnotes:

*Case counts for reporting years 2021 and 2022 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
National Hospital Care Survey 2013-2016, 2019-2021, restricted data

The National Hospital Care Survey (NHCS) is designed to provide accurate and reliable health care statistics that answer key questions of interest to health care and public health professionals, researchers, and health care policy makers. This includes tracking the latest trends affecting hospitals and health care organizations and factors that influence the use of health care resources, the quality of health care, and disparities in health care services provided to population subgroups in the United States.
NHCS collects data on patient care in hospital-based settings to describe patterns of health care delivery and utilization in the United States. Settings include inpatient, emergency (EDs), and outpatient departments (OPDs). The survey will provide hospital utilization statistics for the Nation. In addition, NHCS will also be able to monitor national trends in substance use-related ED visits including opioid visits.
Managed Care Institutional Provider Network Data: September 30, 2012

The primary purpose for the Provider Network Data System is to collect data needed to evaluate the provider networks including physicians, hospitals, labs, home health agencies, durable medical equipment providers, etc., for all types of Managed Care plans in New York State, including HIV Special Need Plans (SNP), Family Health Plus (FHP) Buy-In, Programs of All-Inclusive Care for the Elderly (PACE), and Non-PACE Managed Long-Term Care (MLTC) plans.

This dataset reflects institutional provider data.

Provider Network Data System information is self-reported.

For more information, check out http://www.health.ny.gov/health_care/managed_care/.
Compound 525685: p-Chlorobenzylidene-cyclohexyl-amine

Chemical compound data from PubChem database. IUPAC Name: 1-(4-chlorophenyl)-N-cyclohexylmethanimine. Molecular Formula: C13H16ClN. Molecular Weight: 221.72. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401505-T1: [Translated] DEVICE FOR FASTENING A TENSIONED FABRIC

A device for fixing a fabric includes a frame of polygonal shape that is able to accommodate at least one insert, whereby the fabric is wedged between the frame and the insert, the frame includes a groove with a shrunken mouth, and the insert includes a horseshoe-shaped body that can be deformed elastically and can be inserted forcibly into the groove, characterized in that the body includes, on the one hand, a first wall that delimits a housing that opens toward the outside, and, on the other hand, a second wall that defines a retaining surface that can work with the groove, whereby a recess is arranged between the two walls (26, 32) so as to make the deformations of each wall (26, 32) independent, whereby junction zones are provided to connect the first wall and the second wall on both sides of the mouth of the housing.
Compound 530397: 1,5-Octadiene, 3-ethyl-

Chemical compound data from PubChem database. IUPAC Name: 3-ethylocta-1,5-diene. Molecular Formula: C10H18. Molecular Weight: 138.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
West: 2011-2012 NSDUH

This report presents the West\'s (e.g., combines Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming) estimates for 25 measures of substance use and mental health based on the combined 2011 and 2012 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for the West for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.